Stonebridge Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$81.9K |
| 2 |
General Dynamics
GD
|
+$46K |
| 3 |
Dollar Tree
DLTR
|
+$15.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.31M |
| 2 |
Gilead Sciences
GILD
|
+$1.91M |
| 3 |
NVIDIA
NVDA
|
+$925K |
| 4 |
Oracle
ORCL
|
+$835K |
| 5 |
Intuit
INTU
|
+$781K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.06% |
| 2 | Healthcare | 15.49% |
| 3 | Consumer Staples | 12.38% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Discretionary | 6.48% |
Similar funds
Stonebridge Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Stonebridge Capital Management held 100 positions worth $219M, down 21% from $277M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Stonebridge Capital Management withdrew a net $18.7M in Q2 2022, closing 3 positions and reducing 46 holdings. Its most notable exit was Gilead Sciences, an estimated $1.91M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Stonebridge Capital Management added an estimated $81.9K to Tesla.
- Stonebridge Capital Management added most to Tesla in Q2 2022, an estimated $81.9K increase.
- Stonebridge Capital Management's biggest Q2 2022 reduction was Apple, cutting an estimated $3.31M.
- Stonebridge Capital Management fully exited Gilead Sciences in Q2 2022, selling an estimated $1.91M.
- Stonebridge Capital Management's ten largest holdings make up 47% of its $219M portfolio in Q2 2022.
- Stonebridge Capital Management opened 1 new position and closed 3 in Q2 2022.
- Stonebridge Capital Management's portfolio value fell 21% quarter-over-quarter to $219M.
Based on Stonebridge Capital Management's 13F filing for Q2 2022, filed 1 Jul 2022.